Azenta reports nomination of Tina Nova, Dorothy Puhy to board of directors

Azenta announced that Tina S. Nova, Ph.D. and Dorothy E. Puhy have been nominated for election to its Board of Directors at the Company’s 2023 Annual General Meeting. They will join as non-voting observers of the company’s Board of Directors with immediate effect. Tina S. Nova, Ph.D. currently serves as President of Veracyte’s CLIA U.S. Business. Dorothy E. Puhy spent 25 years at the Dana-Farber Cancer Institute, most recently serving as EVP and Chief Operating Officer.